121 related articles for article (PubMed ID: 11173919)
41. Ischemia/reperfusion-induced feline intestinal dysfunction: importance of granulocyte recruitment.
Kubes P; Hunter J; Granger DN
Gastroenterology; 1992 Sep; 103(3):807-12. PubMed ID: 1323498
[TBL] [Abstract][Full Text] [Related]
42. Propofol prevents lung injury after intestinal ischemia-reperfusion by inhibiting the interaction between mast cell activation and oxidative stress.
Zhao W; Zhou S; Yao W; Gan X; Su G; Yuan D; Hei Z
Life Sci; 2014 Jul; 108(2):80-7. PubMed ID: 24878149
[TBL] [Abstract][Full Text] [Related]
43. Ketotifen abrogates local and systemic consequences of rat intestinal ischemia-reperfusion injury.
Kalia N; Brown NJ; Wood RF; Pockley AG
J Gastroenterol Hepatol; 2005 Jul; 20(7):1032-8. PubMed ID: 15955211
[TBL] [Abstract][Full Text] [Related]
44. Mucosal mast cell proteases are involved in colonic permeability alterations and subsequent bacterial translocation in endotoxemic rats.
Moriez R; Leveque M; Salvador-Cartier C; Barreau F; Theodorou V; Fioramonti J; Bueno L; Eutamene H
Shock; 2007 Jul; 28(1):118-24. PubMed ID: 17510603
[TBL] [Abstract][Full Text] [Related]
45. Anti-inflammatory and antioxidant effects of infliximab in a rat model of intestinal ischemia/reperfusion injury.
Pergel A; Kanter M; Yucel AF; Aydin I; Erboga M; Guzel A
Toxicol Ind Health; 2012 Nov; 28(10):923-32. PubMed ID: 22082824
[TBL] [Abstract][Full Text] [Related]
46. Role of granulocyte-macrophage colony-stimulating factor on apoptosis induced by ischemia-reperfusion in the intestinal epithelium.
Bedirli A; Soyuer I; Muhtaroglu S; Guler I
Eur Surg Res; 2003; 35(4):357-62. PubMed ID: 12802097
[TBL] [Abstract][Full Text] [Related]
47. Soluble complement receptor type 1 ameliorates the local and remote organ injury after intestinal ischemia-reperfusion in the rat.
Hill J; Lindsay TF; Ortiz F; Yeh CG; Hechtman HB; Moore FD
J Immunol; 1992 Sep; 149(5):1723-8. PubMed ID: 1387151
[TBL] [Abstract][Full Text] [Related]
48. Sustained nitric oxide production via l-arginine administration ameliorates effects of intestinal ischemia-reperfusion.
Ward DT; Lawson SA; Gallagher CM; Conner WC; Shea-Donohue T
J Surg Res; 2000 Mar; 89(1):13-9. PubMed ID: 10720447
[TBL] [Abstract][Full Text] [Related]
49. Mesna protects intestinal mucosa from ischemia/reperfusion injury.
Ypsilantis P; Lambropoulou M; Tentes I; Kortsaris A; Papadopoulos N; Simopoulos C
J Surg Res; 2006 Aug; 134(2):278-84. PubMed ID: 16500680
[TBL] [Abstract][Full Text] [Related]
50. Effect of Intervention in Mast Cell Function Before Reperfusion on Renal Ischemia-Reperfusion Injury in Rats.
Tong F; Luo L; Liu D
Kidney Blood Press Res; 2016; 41(3):335-44. PubMed ID: 27304487
[TBL] [Abstract][Full Text] [Related]
51. Thrombosis increases circulatory hepatocyte growth factor by degranulation of mast cells.
Kinoshita M; Miyamoto T; Ohashi N; Sasayama S; Matsumori A
Circulation; 2002 Dec; 106(24):3133-8. PubMed ID: 12473563
[TBL] [Abstract][Full Text] [Related]
52. The role of epidermal growth factor in prevention of oxidative injury and apoptosis induced by intestinal ischemia/reperfusion in rats.
Arda-Pirincci P; Bolkent S
Acta Histochem; 2014 Jan; 116(1):167-75. PubMed ID: 23932386
[TBL] [Abstract][Full Text] [Related]
53. Attenuating effect of Myakuryu on mesenteric microcirculatory disorders induced by ischemia and reperfusion.
Han JY; Horie Y; Li D; Akiba Y; Nagata H; Miura S; Oda M; Ishii H; Hibi T
Clin Hemorheol Microcirc; 2006; 34(1-2):145-50. PubMed ID: 16543630
[TBL] [Abstract][Full Text] [Related]
54. Ulinastatin, a protease inhibitor, attenuates intestinal ischemia/reperfusion injury.
Li XK; Suzuki H; Kimura T; Kawabe A; Uno T; Harada Y
Transplant Proc; 1994 Aug; 26(4):2423-5. PubMed ID: 8066795
[No Abstract] [Full Text] [Related]
55. Mucosal permeability to 51Cr EDTA following subclinical intestinal ischemia-reperfusion injury in the weanling rat.
Langer JC; Sohal SS; Riddell RH
J Pediatr Surg; 1993 Apr; 28(4):601-5. PubMed ID: 8483076
[TBL] [Abstract][Full Text] [Related]
56. Effects of peripherally and centrally applied ghrelin in the pathogenesis of ischemia-reperfusion induced injury of the small intestine.
Pawlik MW; Obuchowicz R; Biernat J; Szczepanski W; Pajdo R; Kwiecień S; Brzozowski T; Konturek SJ; Pawlik WW
J Physiol Pharmacol; 2011 Aug; 62(4):429-39. PubMed ID: 22100844
[TBL] [Abstract][Full Text] [Related]
57. Role of mucosal mast cells in visceral hypersensitivity in a rat model of irritable bowel syndrome.
La JH; Kim TW; Sung TS; Kim HJ; Kim JY; Yang IS
J Vet Sci; 2004 Dec; 5(4):319-24. PubMed ID: 15613815
[TBL] [Abstract][Full Text] [Related]
58. Impact of vasoactive intestinal polypeptide and gastrin-releasing peptide on small bowel microcirculation and mucosal injury after hepatic ischemia/reperfusion in rats.
Leister I; Sydow J; Stojanovic T; Füzesi L; Sattler B; Heuser M; Becker H; Markus PM
Int J Colorectal Dis; 2005 Jan; 20(1):42-8. PubMed ID: 15602648
[TBL] [Abstract][Full Text] [Related]
59. The role of mast cells in ischemia and reperfusion injury.
Yang MQ; Ma YY; Ding J; Li JY
Inflamm Res; 2014 Nov; 63(11):899-905. PubMed ID: 25108401
[TBL] [Abstract][Full Text] [Related]
60. Roles of mucosal mast cells in intestinal cell-mediated immunity.
Ferguson A; Cummins AG; Munro GH; Gibson S; Miller HR
Ann Allergy; 1987 Nov; 59(5 Pt 2):40-3. PubMed ID: 3479922
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
